Markets finish week down after bouncing on Bannon's exit >>> READ MORE

InvestorPlace’s 10 Best Stocks of 2013: Mid-Year Standings

It's a tight race, including two ties in the top five

      View All  

#4: Mylan

Q2 Return: +7%
YTD Return:
Rick Pendergraft

Mylan (MYL) is proof that sometimes, slow and steady is the way to go. The stock was hanging around in sixth place at the end of the first quarter with a decent 5% climb.

Unlike some of the previous picks, though, it actually kept on climbing. In fact, Mylan’s total return is just behind the broader market’s — and that’s good enough for a fourth-place halftime finish.

The pharma company — chosen by Rick Pendergraft for its strong technicals and fundamentals — gained momentum in early May after reporting a 19% year-over-year improvement in earnings and maintained its outlook. It also has made more recent headlines for launching a generic version of Viagra in 11 European countries.

If the good news keeps coming, Pendergraft might just be proved correct in his hypothesis of 30% upside.

Halfway through the year, he’s basically halfway there.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC